Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial

Guy de Bruyn, David Gordon, Theodore S. Steiner, Paul Anantharajah Tambyah, Catherine Cosgrove, Mark G. Martens, Ehab Bassily, Eng-Soon Chan, Dhaval M. Patel, Josh Chen, Julián Torre‐Cisneros, Carlos Fernando de Magalhães Francesconi, Richard Gesser, Robert Jeanfreau, Odile Launay, Thelma Laot, Rayo Morfín‐Otero, Ernesto Oviedo‐Orta, Yoon Soo Park, Franco M. Piazza, Christine Rehm, Enrique Rivas, Steve Self, Sanjay Gurunathan